Print ISSN: 2394-2746
Online ISSN: 2394-2754
CODEN : IJOGCS
Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Case Report
Author Details :
Volume : 6, Issue : 3, Year : 2019
Article Page : 402-404
https://doi.org/10.18231/j.ijogr.2019.088
Abstract
Blood transfusion is an accepted life saving therapeutic procedure in obstetrics and all specialities of
medicine and few chronic or immune disorders of dermatology like chronic vascular disease and bullous
dermatosis. We report a unique case of adverse dermatological lesion following severe blood transfusion
reaction in an unbooked 28 year G3 P2 L2 with 29+2 weeks pregnancy with severe anemia, first of its kind
in my 31 year of clinical experience as consultant obstetri cian. Blood transfusion, a life saving procedure
should only be given at secondary or tertiary care hospitals. Attending doctor must have a vigil eye to
recognize any adverse dermatological lesions due to blood transfusion reaction with HDU ready to manage
every catastrophic eventuality.
Keywords: Blood transfusion, Adverse dermatological lesions, Graft versus host disease, Pregnancy, Purpura.
How to cite : Bhatia R, Mor S, Aneet, Manocha M, Vashisht N, Adverse dermatology lesions following acute blood reaction in pregnancy: A case report. Indian J Obstet Gynecol Res 2019;6(3):402-404
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.